IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.946
NA - Nord America 10.910
EU - Europa 4.280
SA - Sud America 1.329
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 176
OC - Oceania 60
AN - Antartide 1
Totale 38.883
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 15.135
US - Stati Uniti d'America 10.480
CN - Cina 2.987
IT - Italia 2.147
HK - Hong Kong 2.115
BR - Brasile 954
GB - Regno Unito 632
VN - Vietnam 572
FR - Francia 533
BD - Bangladesh 301
DE - Germania 272
IN - India 233
CA - Canada 225
AR - Argentina 150
NL - Olanda 148
MX - Messico 126
ID - Indonesia 87
ZA - Sudafrica 76
JP - Giappone 75
TR - Turchia 75
FI - Finlandia 66
UA - Ucraina 64
AU - Australia 54
PL - Polonia 52
ES - Italia 50
RU - Federazione Russa 48
CO - Colombia 47
IQ - Iraq 45
SA - Arabia Saudita 45
EC - Ecuador 43
CL - Cile 34
SE - Svezia 34
PH - Filippine 32
PY - Paraguay 31
MD - Moldavia 27
UZ - Uzbekistan 27
CZ - Repubblica Ceca 26
PE - Perù 26
PK - Pakistan 26
EE - Estonia 25
VE - Venezuela 24
AT - Austria 20
CH - Svizzera 20
MY - Malesia 17
BE - Belgio 16
JM - Giamaica 16
LT - Lituania 15
TW - Taiwan 14
KE - Kenya 13
KR - Corea 13
AZ - Azerbaigian 12
EG - Egitto 12
NP - Nepal 12
TN - Tunisia 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
BH - Bahrain 11
CR - Costa Rica 11
IR - Iran 11
RO - Romania 11
TH - Thailandia 11
MA - Marocco 10
GT - Guatemala 9
IL - Israele 9
JO - Giordania 9
PS - Palestinian Territory 9
RS - Serbia 9
DZ - Algeria 8
PT - Portogallo 8
SI - Slovenia 8
HN - Honduras 7
OM - Oman 7
AL - Albania 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GR - Grecia 6
KZ - Kazakistan 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
IE - Irlanda 5
LB - Libano 5
NI - Nicaragua 5
SN - Senegal 5
SV - El Salvador 5
BO - Bolivia 4
CI - Costa d'Avorio 4
CY - Cipro 4
DM - Dominica 4
GH - Ghana 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
BF - Burkina Faso 3
BY - Bielorussia 3
HU - Ungheria 3
LV - Lettonia 3
ML - Mali 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 38.639
Salva come PNG Salva come JPEG
Città #
San Jose 3.138
Ashburn 2.185
Hong Kong 2.088
Singapore 1.969
Rome 1.363
Hefei 1.088
Council Bluffs 697
Boardman 659
Beijing 620
Columbus 559
London 510
Lauterbourg 473
Dallas 461
Shanghai 362
Santa Clara 278
Ho Chi Minh City 198
Los Angeles 179
New York 154
Hanoi 125
San Francisco 123
Munich 101
São Paulo 99
Amsterdam 87
Pune 79
Toronto 79
Mexico City 78
Seattle 74
Milan 72
Washington 57
Tokyo 49
Warsaw 48
Johannesburg 42
Frankfurt am Main 41
Turku 40
Brooklyn 39
Chicago 38
Chennai 37
Rio de Janeiro 35
Montreal 32
St Louis 29
Naples 27
Orem 27
Boston 26
Las Vegas 26
Melbourne 26
Stockholm 26
Da Nang 25
Helsinki 25
Phoenix 23
Tashkent 23
Riyadh 22
Turin 21
Brno 20
Hangzhou 20
Secaucus 20
Atlanta 19
Biên Hòa 19
Haiphong 19
Buenos Aires 18
Belo Horizonte 17
Bologna 17
Buffalo 17
Charlotte 17
Manchester 17
New Delhi 17
Ankara 16
Asunción 16
Curitiba 16
Palermo 16
Sydney 16
Denver 15
Guangzhou 15
The Dalles 15
Baghdad 14
Istanbul 14
Bari 13
Jeddah 13
Quito 13
Thái Bình 13
Canberra 12
Central 12
Hasselt 12
Miami 12
Nairobi 12
Porto Alegre 12
Santiago 12
West Jordan 12
Bogotá 11
Brasília 11
Florence 11
Lima 11
Moscow 11
Philadelphia 11
San José 11
Dhaka 10
Kingston 10
Medellín 10
Modena 10
Ribeirão Preto 10
Salvador 10
Totale 19.357
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 342
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 304
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 277
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 261
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 256
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 254
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 251
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 250
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 247
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 244
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 244
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 243
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 242
Cardiotossicità da antracicline 239
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 235
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 234
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 234
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 229
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 226
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 225
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 225
Premetastatic niche: ready for new therapeutic interventions? 220
Prevention of radiotherapy-induced emesis 220
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 218
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 218
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 217
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 217
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 215
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 215
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 213
Urinary complications from breast cancer metastasis: case report and review of the literature 211
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 210
Docetaxel induced pericardial effusion 208
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 207
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 207
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 205
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 205
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 204
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 203
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 202
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 199
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 198
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 194
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 193
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 180
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 170
A giant sarcoma of the parotid gland: A case report and review of the literature 166
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 157
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 156
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 149
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 146
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 145
Italian translation of the Manchester-Oxford Foot Questionnaire (MOXFQ), with re-assessment of reliability and validity 144
'Old' and 'new' drugs for the treatment of cancer pain 144
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 142
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 141
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 140
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 139
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 138
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 138
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 135
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 135
An international survey on the use of guidelines for palliative sedation therapy 134
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 134
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 133
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 132
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 130
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 129
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 128
Biological effects of cabozantinib on bone microenvironment 128
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 127
Activity of sirolimus in patients with progressive epithelioid hemangioendothelioma: A case-series analysis within the Italian Rare Cancer Network 126
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 126
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 126
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 123
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 121
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 121
Azygo-tracheal fistula in a complete implantable central venous system 120
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 119
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 119
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 119
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 118
Atypical chronic head and neck pain: don't forget Eagle's syndrome 118
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 118
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 116
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 116
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 116
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 115
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 115
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 114
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 114
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 114
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 113
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial 113
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 112
Idiosyncratic reaction after oxaliplatin infusion 112
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 109
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 108
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 108
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study 104
Totale 17.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 275.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 275.745
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022753 0 9 12 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/202617.017 1.506 684 1.068 1.806 640 1.043 4.379 1.462 1.403 1.549 775 702
2026/20271.634 344 1.290 0 0 0 0 0 0 0 0 0 0
Totale 38.883